{
  "retracted": false,
  "timestamp": 1510531200000,
  "updates": [
    {
      "timestamp": 1585481971681,
      "identifier": {
        "doi": "10.1007/s00535-017-1409-z"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s00535-017-1396-0"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection"
}
